Glaxo Rises, Gilead Falls on HIV Drug News
GlaxoSmithKline (GSK) is rising this morning, after the company announced that its experimental HIV treatment dolutegravir reduced the level of the virus in the blood of patients who had taken it in conjunction with two other drugs. The company claimed that the treatment actually reduced the virus more than Gilead’s (GILD) Atripla, which is the [...]
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here